DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
IODOFILTIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IODOFILTIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
S36MQ9FKF0
Molecule Type:
Small molecule
Molecular Formula:
C22H35IO2
Molecular Weight:
458.42
AlogP:
7.24
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT
2
Enzyme
Investigational
Unknown
Unknown
Mucopolysaccharidoses
Unknown
N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VICRIVIROC MALEATE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
C-C chemokine receptor type 5 antagonist
VICRIVIROC MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
EP3QG127N9
Molecule Type:
Small molecule
Molecular Formula:
C32H42F3N5O6
Molecular Weight:
649.71
AlogP:
4.5
PSA:
61.8
HBD:
0.0
HBA:
#RotB:
6.0
Source:
HYDROXYTYROSOL
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
HYDROXYTYROSOL
×
Maximum Phase:
2
First Approval:
None
UNII:
QEU0NE4O90
Molecule Type:
Small molecule
Molecular Formula:
C9H12O3
Molecular Weight:
168.19
AlogP:
1.02
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
SECOISOLARICIRESINOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SECOISOLARICIRESINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIL-21
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
RIL-21
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NANGIBOTIDE
2
Protein
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome; Shock, Septic
Triggering receptor expressed on myeloid cells 1 inhibitor
NANGIBOTIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
59HD7BLX9H
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEPILAMIDE FUMARATE
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
TEPILAMIDE FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
KOS9TZ09CM
Molecule Type:
Small molecule
Molecular Formula:
C11H17NO5
Molecular Weight:
243.26
AlogP:
0.13
PSA:
72.91
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IMD-1041
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-1041
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRADEFOVIR MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic
DNA polymerase/reverse transcriptase inhibitor
PRADEFOVIR MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
0D5204ZSIX
Molecule Type:
Small molecule
Molecular Formula:
C18H23ClN5O7PS
Molecular Weight:
519.9
AlogP:
3.41
PSA:
114.38
HBD:
1.0
HBA:
#RotB:
6.0
Source:
DOMPERIDONE MALEATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOMPERIDONE MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAROTROPIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAROTROPIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
9ZQX4PG68I
Molecule Type:
Small molecule
Molecular Formula:
C24H29N2+
Molecular Weight:
345.51
AlogP:
4.9
PSA:
23.79
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NS-018
2
Small molecule
Investigational
Unknown
Unknown
Primary Myelofibrosis
Tyrosine-protein kinase JAK2 inhibitor
NS-018
×
Maximum Phase:
2
First Approval:
None
UNII:
56R994WX4L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIRIDAVUMAB
2
Antibody
Investigational
Unknown
Unknown
Influenza, Human; Orthomyxoviridae Infections
Hemagglutinin inhibitor
DIRIDAVUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
JFC86A9HL9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TORAPSEL
2
Protein
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases
Unknown
TORAPSEL
×
Maximum Phase:
2
First Approval:
None
UNII:
SU09HUV8AJ
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OMBIPEPIMUT-S
2
Unknown
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Glioblastoma
Wilms tumor protein vaccine antigen
OMBIPEPIMUT-S
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TORUDOKIMAB
2
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic
Interleukin-33 inhibitor
TORUDOKIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACYL-GHRELIN
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ACYL-GHRELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALDEFGROBEP ALFA
2
Protein
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Unknown
TALDEFGROBEP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
766C38JSAR
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOPENTYL 2-CYANOACRYLATE
2
Small molecule
Investigational
Unknown
Unknown
Infertility; Hypospadias
Unknown
ISOPENTYL 2-CYANOACRYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3977IRA64J
Molecule Type:
Small molecule
Molecular Formula:
C9H13NO2
Molecular Weight:
167.21
AlogP:
1.66
PSA:
50.09
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DHAP
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DHAP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIDECANOIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRIDECANOIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESCIN
2
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
ESCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
RUU8G67GQM
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLACAFTOR
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Cystic fibrosis transmembrane conductance regulator positive modulator
OLACAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
RZ7027HK8F
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN3O4S
Molecular Weight:
539.67
AlogP:
5.67
PSA:
88.6
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OXALOBACTER FORMIGENES
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
OXALOBACTER FORMIGENES
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PERILLYL ALCOHOL
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Lymphoma; Breast Neoplasms; Keratosis, Actinic; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
PERILLYL ALCOHOL
×
Maximum Phase:
2
First Approval:
None
UNII:
3UL4QIY642
Molecule Type:
Small molecule
Molecular Formula:
C10H16O
Molecular Weight:
152.24
AlogP:
2.28
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
2.0
Source:
P-276-00
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Lymphoma, Mantle-Cell; Melanoma
Unknown
P-276-00
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO5
Molecular Weight:
367.4
AlogP:
2.65
PSA:
94.14
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AMELPARIB DIHYDROCHLORIDE DIHYDRATE
2
Unknown
Investigational
Unknown
Unknown
Stroke; Ischemic Stroke
Unknown
AMELPARIB DIHYDROCHLORIDE DIHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H15GT9J2LB
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEPADUTANT
2
Small molecule
Investigational
Unknown
Unknown
Abdominal Pain
Unknown
NEPADUTANT
×
Maximum Phase:
2
First Approval:
None
UNII:
XW59TYL1XH
Molecule Type:
Small molecule
Molecular Formula:
C45H58N10O13
Molecular Weight:
947.02
AlogP:
-4.11
PSA:
347.61
HBD:
13.0
HBA:
#RotB:
11.0
Source:
BRANEBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
BRANEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
7LBRZUYSHU
Molecule Type:
Small molecule
Molecular Formula:
C20H23FN4O2
Molecular Weight:
370.43
AlogP:
2.13
PSA:
91.22
HBD:
3.0
HBA:
#RotB:
3.0
Source:
CARICOTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
CARICOTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MC09H30MFS
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O2
Molecular Weight:
181.19
AlogP:
-0.94
PSA:
89.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FAD
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FAD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TELAZORLIMAB
2
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic
Tumor necrosis factor receptor superfamily member 4 antagonist
TELAZORLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
0CRN540O4R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SONEPCIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Renal Cell; Macular Degeneration
Sphingosine 1-phosphate inhibitor
SONEPCIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
O4T5UXS4P2
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELETALISIB
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis; Sjogren's Syndrome
PI3-kinase p110-delta subunit inhibitor
SELETALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
64CW205BDD
Molecule Type:
Small molecule
Molecular Formula:
C23H14ClF3N6O
Molecular Weight:
482.85
AlogP:
5.24
PSA:
90.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
130
131
132
133
134
135
136
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA